CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomes

CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomes

Bibliographic Details
Main Authors: Evandro D. Bezerra, Terra L. Lasho, Christy M. Finke, Antoine N. Saliba, Michelle A. Elliott, Animesh D. Pardanani, Naseema Gangat, Abhishek A. Mangaonkar, Rhett P. Ketterling, Ayalew Tefferi, Eric Solary, Mrinal M. Patnaik
Format: Article
Language:English
Published: Nature Publishing Group 2021-03-01
Series:Blood Cancer Journal
Online Access:https://doi.org/10.1038/s41408-021-00449-9

Internet

https://doi.org/10.1038/s41408-021-00449-9

Similar Items